UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

The lancet oncology, 2018-03, Vol.19 (3), p.370-381

2018

Link zum Volltext

Verfügbarkeit prüfen

The use of the Hellwig's method for feature selection in the detection of myeloma bone destruction based on radiographic images

Biocybernetics and biomedical engineering, 2019-04, Vol.39 (2), p.328-338

2019

Link zum Volltext

Verfügbarkeit prüfen

ECDIS Users Genuine Qualification in Maritime Industry Great Demand

TransNav (Gdynia, Poland ), 2016-12, Vol.10 (4), p.575-579

Legiec, Wojciech

2016

Link zum Volltext

Verfügbarkeit prüfen

Position Cross-Checking on ECDIS in View of International Regulations Requirements and OCIMF Recommendations

TransNav (Gdynia, Poland ), 2016-04, Vol.10 (1), p.105-113

Legiec, Wojciech

2016

Link zum Volltext

Verfügbarkeit prüfen

New drugs in multiple myeloma – role of carfilzomib and pomalidomide

Contemporary oncology (Poznań, Poland), 2014-01, Vol.18 (1), p.17-21

2014

Link zum Volltext

Verfügbarkeit prüfen

Transplantacje komórek krwiotwórczych w przewlekłej białaczce limfocytowej

Acta haematologica polonica, 2014-04, Vol.45 (2), p.132-136

2014

Link zum Volltext

Verfügbarkeit prüfen

Review: New drugs in multiple myeloma - role of carfilzomib and pomalidomide

Contemporary oncology (Poznań, Poland), 2014-01, Vol.18 (1), p.17

2014

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-10, Vol.375 (14), p.1319-1331

2016

Link zum Volltext

Verfügbarkeit prüfen

OCEAN (OP-103): Melflufen Plus Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM) - Renal Impairment (RI) Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.4777-4777

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis

Folia histochemica et cytobiologica, 2011-01, Vol.49 (2), p.248-254

2011

Link zum Volltext

Verfügbarkeit prüfen

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

The Lancet. Haematology, 2022-02, Vol.9 (2), p.e98-e110

2022

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

Annals of hematology, 2011-10, Vol.90 (10), p.1161-1166

2011

Link zum Volltext

Verfügbarkeit prüfen

Massive bleeding episodes in patients with acquired haemophilia--case report

Polskie archiwum medycyny wewne̦trznej, 2006-04, Vol.115 (4), p.351

2006

Link zum Volltext

Verfügbarkeit prüfen

An International, Randomized, Double Blind Trial Comparing Denosumab With Zoledronic Acid (ZA) for the Treatment of Bone Disease in Patients (Pts) With Newly Diagnosed Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2017-02, Vol.17 (1), p.e27-e28

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Blood, 2015-12, Vol.126 (23), p.3034-3034

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of Biosimilar G-CSF Is Effective After Autologous Bone Marrow Transplantation

Blood, 2011-11, Vol.118 (21), p.5321-5321

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Blood, 2013-11, Vol.122 (21), p.3236-3236

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Blood, 2011-11, Vol.118 (21), p.5125-5125

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)
Tagungsberichte
(1)

Sprache

Englisch
(28)
Polnisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(13)
Humans
(11)
Female
(9)
Hematology
(9)
Male
(9)
Middle Aged
(9)
Multiple Myeloma
(9)
Aged
(8)
Multiple Myeloma - Drug Therapy
(6)
Oncology
(6)
Adult
(5)
Patients
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Autografts
(4)
Medicin Och Hälsovetenskap
(4)
Stem Cell Transplantation
(4)
Survival Analysis
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis

The use of the Hellwig's method for feature selection in the detection of myeloma bone destruction based on radiographic images

Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma

ECDIS Users Genuine Qualification in Maritime Industry Great Demand

Position Cross-Checking on ECDIS in View of International Regulations Requirements and OCIMF Recommendations

New drugs in multiple myeloma – role of carfilzomib and pomalidomide

Transplantacje komórek krwiotwórczych w przewlekłej białaczce limfocytowej

Review: New drugs in multiple myeloma - role of carfilzomib and pomalidomide

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

OCEAN (OP-103): Melflufen Plus Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM) - Renal Impairment (RI) Analysis

Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors

Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

Efficacy and safety of the randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients (pts) with relapsed or refractory multiple myeloma (RRMM): COLUMBA

OAB-050: OCEAN (OP-103): a Phase 3, randomized, global, head-to-head comparison study of Melflufen and Dexamethasone (Dex) versus Pomalidomide (Pom) and Dex in Relapsed Refractory Multiple Myeloma (RRMM)

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

Massive bleeding episodes in patients with acquired haemophilia--case report

An International, Randomized, Double Blind Trial Comparing Denosumab With Zoledronic Acid (ZA) for the Treatment of Bone Disease in Patients (Pts) With Newly Diagnosed Multiple Myeloma

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Use of Biosimilar G-CSF Is Effective After Autologous Bone Marrow Transplantation

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, non-interventional study

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Suchergebnisse filtern